AMARIN CORP PLC\UK Other Non-Current Liabilities
AMARIN CORP PLC\UK (AMRN) had Other Non-Current Liabilities of $11.30 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-07-29
- 2026-06-30: Other Liabilities, Noncurrent $11.30M.
- 2026-03-31: Other Liabilities, Noncurrent $11.12M.
- 2025-12-31: Other Liabilities, Noncurrent $10.96M.
- 2025-09-30: Other Liabilities, Noncurrent $11.96M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $11.30M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $11.12M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $10.96M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $11.96M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $11.92M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $11.64M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $11.50M 10-K · filed 2026-03-02 |
| 2024-09-30 | $9.47M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $9.34M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $9.20M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $9.06M 10-K · filed 2025-03-12 |
| 2023-09-30 | $7.27M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $7.16M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $8.61M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $8.21M 10-K · filed 2024-02-29 |
| 2022-09-30 | $9.70M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $7.64M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $7.49M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $7.65M 10-K · filed 2023-03-01 |
| 2021-09-30 | $5.35M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $5.53M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $5.66M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $6.21M 10-K · filed 2022-03-01 |
| 2020-09-30 | $4.30M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $4.82M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $2.67M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $3.75M 10-K · filed 2021-02-25 |
| 2019-09-30 | $5.40M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $6.81M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $8.03M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $10.52M 10-K · filed 2020-02-25 |
| 2018-09-30 | $8.65M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $6.76M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $1.15M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $1.15M 10-K · filed 2019-02-27 |
| 2017-09-30 | $1.16M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $1.16M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $1.17M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $710.00K 10-K · filed 2018-02-27 |
| 2016-09-30 | $731.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $268.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $300.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $335.00K 10-K · filed 2017-03-01 |
| 2015-09-30 | $608.00K 10-Q · filed 2015-11-04 |
| 2015-06-30 | $626.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $631.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $386.00K 10-K · filed 2016-02-25 |
| 2014-09-30 | $640.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $619.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $632.00K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $658.00K 10-K · filed 2015-03-03 |
| 2013-09-30 | $811.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $795.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $807.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $816.00K 10-K · filed 2014-02-27 |
| 2012-09-30 | $702.00K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $704.00K 10-Q · filed 2012-08-08 |
| 2011-12-31 | $764.00K 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |